SA
PFE icon

Strategic Advisors’s Pfizer PFE Stock Holding History

Strategic Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$26.5K – 199
2024
Q4 		$26.5K Buy
+1,000
New +$27.1K ﹤0.01% 197

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Strategic Advisors's PFE Position: Q1 2026 in Review

Strategic Advisors increased its Pfizer (PFE) stake by 16% in Q1 2026, buying an estimated $75.3K and bringing the position to 20,151 shares worth $566K. The position accounts for 0.09% of the portfolio, ranked #127.

Strategic Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.12M in Q1 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Strategic Advisors held 20,151 shares of Pfizer worth $566K as of Q1 2026.
  • Strategic Advisors bought 2,829 Pfizer shares in Q1 2026, an estimated $75.3K.
  • Pfizer made up 0.09% of Strategic Advisors's portfolio in Q1 2026, its #127 holding.
  • Strategic Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Strategic Advisors's Pfizer position peaked at $8.12M in Q1 2022.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Strategic Advisors's 13F filing for Q1 2026, filed 14 May 2026.